The Cost-Effectiveness of Sequential First- and Second-Line Treatments in Metastatic Renal Cell Carcinoma Using Real-World Data and a Patient-Level Simulation Model
Abstract
Authors
S. de Groot H. Blommestein W. Redekop E. Oosterwijk L. Kiemeney G.root C Uyl- de